… infection, prophylactic and therapeutic anticoagulation were … who did not receive
anticoagulation. In adjusted analyzes, a … anticoagulation compared to prophylactic …

… effects of anticoagulant prophylaxis during the time patients were receiving prophylaxis, we
… treatment effects of anticoagulant prophylaxis were maintained after prophylaxis had been …

… Subsequently, the inflammation and the thrombotic milieu also affect the microcirculation of
… of anticoagulant therapy (prophylactic vs full dose) and the exact time to start anticoagulants …

… were brought to anticoagulant therapeutic and prophylactic strategies. Today, … oral
anticoagulant for NVAF patients aged above 75 years and for those with a history of arterial …

… anticoagulation and its inherent side effects. A study on 81 severe COVID-19 patients from
Wuhan, with no preventive anticoagulant … of 75% of patients with no thrombotic events and, …

… by thrombotic events that require life-long anticoagulation [125]. … of anticoagulation and
duration of prophylactic anticoagulation … Importantly, the benefits of prophylactic anticoagulation …

… develop a severe pro-thrombotic milieu, as reflected by the … ance for the antithrombotic
prophylaxis and treatment of VTE as … prolonged prophylactic anticoagulant therapy with heparin or …

… perioperative bridging anticoagulation without thrombotic risk … catheter, therapeutic
anticoagulation must be administered … in case of prophylactic anticoagulation doses that do not …

… , resulting in a greater prothrombotic milieu and more myocardial damage in patients with
ACS. … indications for therapeutic anticoagulation should receive prophylactic doses because of …

… The uncertainty in optimal prophylactic anticoagulant regimen has translated into variability
in expert recommendations, hospital policies, and clinicians’ decisions to use a variety of …